TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Life Genomics AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
30,520
|
30,365
|
43,325 |
| Financial expenses |
2
|
1
|
83 |
| Earnings before taxes |
-1,971
|
-5,236
|
-28,664 |
| EBITDA |
-2,020
|
-5,000
|
-23,288 |
| Total assets |
24,762
|
26,209
|
41,011 |
| Current assets |
23,918
|
24,977
|
39,451 |
| Current liabilities |
5,559
|
5,409
|
16,700 |
| Equity capital |
19,204
|
20,801
|
24,311 |
| - share capital |
465
|
457
|
427 |
| Employees (average) |
7
|
10
|
18 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
77.6%
|
79.4%
|
59.3% |
| Turnover per employee |
4,360
|
3,036
|
2,407 |
| Profit as a percentage of turnover |
-6.5%
|
-17.2%
|
-66.2% |
| Return on assets (ROA) |
-8.0%
|
-20.0%
|
-69.7% |
| Current ratio |
430.3%
|
461.8%
|
236.2% |
| Return on equity (ROE) |
-10.3%
|
-25.2%
|
-117.9% |
| Change turnover |
-392
|
-16,034
|
-72,844 |
| Change turnover % |
-1%
|
-35%
|
-63% |
| Chg. No. of employees |
-3
|
-8
|
-5 |
| Chg. No. of employees % |
-30%
|
-44%
|
-22% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.